Name | Cefepime chloride |
---|
Description | Cefepime (BMY-28142) chloride is a broad-spectrum and cross the blood-brain barrier cephalosporin. Cefepime chloride shows antibacterial effects against both Gram-positive and Gram-negative aerobic bacteria. Cefepime chloride induces neurotoxicity[1][2][3][4]. |
---|---|
Related Catalog | |
In Vitro | Cefepime chloride exerts its antibacterial effects by binding to penicillin-binding proteins[2]. |
In Vivo | Cefepime chloride (80 mg/kg; i.p.) significantly increases the half-life and mice surviveed[4]. Animal Model: Male CD-1 mice[4] Dosage: 80 mg/kg Administration: I.p. Result: Significantly prolonged the half-life of cefepime and all mice survived at 18-22 mg/kg cisplatin, and when pretreatment with 26 mg/kg cisplatin significantly decreased survival with the half-life of cefepime was not significantly longer than of 18 mg/kg cisplatin. |
References |
Molecular Formula | C19H25ClN6O5S2 |
---|---|
Molecular Weight | 517.02 |